topotecan has been researched along with Radiation Pneumonitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bi, N; Chen, D; Feng, Q; Hui, Z; Ji, Z; Liang, J; Liu, L; Lyu, J; Wang, J; Wang, L; Wang, X; Xiao, Z; Yin, W; Zhang, H; Zhou, Z | 1 |
Ji, W; Lü, JM; Ou, GF; Ren, H; Wang, LH; Wang, XZ; Yin, WB; Zhou, ZM | 1 |
2 other study(ies) available for topotecan and Radiation Pneumonitis
Article | Year |
---|---|
[Outcome of concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Cyclophosphamide; Esophagitis; Humans; Lung Neoplasms; Neoplasm Staging; Radiation Pneumonitis; Radiotherapy, Conformal; Retrospective Studies; Topotecan | 2015 |
[Effect of different chemotherapy regimens for concurrent chemoradiotherapy on locally advanced non-small cell lung cancer].
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Proportional Hazards Models; Radiation Pneumonitis; Radiotherapy, Conformal; Retrospective Studies; Survival Rate; Topotecan | 2009 |